Insider Transactions in Q1 2019 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2019
|
Robert M Davis Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
192,572
-58.31%
|
$15,790,904
$82.38 P/Share
|
|
Mar 25
2019
|
Robert M Davis Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
192,572
+36.83%
|
$11,169,176
$58.22 P/Share
|
|
Mar 20
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
192,736
-19.46%
|
$15,804,352
$82.05 P/Share
|
|
Mar 20
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
192,736
+16.29%
|
$7,516,704
$39.29 P/Share
|
|
Mar 13
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
18,725
-2.29%
|
$1,535,450
$82.0 P/Share
|
|
Mar 13
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
18,725
+2.24%
|
$730,275
$39.29 P/Share
|
|
Mar 05
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
6,961
-0.87%
|
$570,802
$82.0 P/Share
|
|
Mar 05
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
6,961
+0.86%
|
$271,479
$39.29 P/Share
|
|
Mar 04
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
13,144
-1.62%
|
$1,077,808
$82.01 P/Share
|
|
Mar 04
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
13,144
+1.6%
|
$512,616
$39.29 P/Share
|
|
Feb 25
2019
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct |
10,380
+14.37%
|
$830,400
$80.38 P/Share
|
|
Feb 25
2019
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+5.72%
|
$321,360
$80.38 P/Share
|
|
Feb 25
2019
|
Robert M Davis Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
30,610
+18.19%
|
$2,448,800
$80.38 P/Share
|
|
Feb 25
2019
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
13,507
+16.06%
|
$1,080,560
$80.38 P/Share
|
|
Feb 25
2019
|
Kenneth C Frazier Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
105,765
+11.71%
|
$8,461,200
$80.38 P/Share
|
|
Feb 25
2019
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,747
+13.66%
|
$699,760
$80.38 P/Share
|
|
Feb 25
2019
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+11.18%
|
$186,400
$80.38 P/Share
|
|
Feb 25
2019
|
Michael Nally EVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,527
+50.0%
|
$122,160
$80.38 P/Share
|
|
Feb 25
2019
|
Roger M Perlmutter Exe V-P & Pres, MRL |
BUY
Grant, award, or other acquisition
|
Direct |
32,937
+15.81%
|
$2,634,960
$80.38 P/Share
|
|
Feb 22
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
53,961
-7.23%
|
$4,316,880
$80.02 P/Share
|
|
Feb 22
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
53,961
+6.75%
|
$2,104,479
$39.29 P/Share
|
|
Feb 21
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
41,992
-5.72%
|
$3,359,360
$80.0 P/Share
|
|
Feb 21
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
41,992
+5.41%
|
$1,637,688
$39.29 P/Share
|
|
Feb 19
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
42,700
-5.81%
|
$3,416,000
$80.02 P/Share
|
|
Feb 19
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
42,700
+5.49%
|
$1,665,300
$39.29 P/Share
|
|
Feb 15
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
92,913
-11.84%
|
$7,433,040
$80.03 P/Share
|
|
Feb 15
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
92,913
+10.59%
|
$3,623,607
$39.29 P/Share
|
|
Feb 14
2019
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Open market or private sale
|
Direct |
64,662
-79.99%
|
$5,043,636
$78.96 P/Share
|
|
Feb 14
2019
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
64,662
+33.23%
|
$3,815,058
$59.04 P/Share
|
|
Feb 13
2019
|
Wendell P Weeks Director |
SELL
Open market or private sale
|
Direct |
5,000
-98.04%
|
$390,000
$78.71 P/Share
|
|
Feb 13
2019
|
Wendell P Weeks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+49.51%
|
$120,000
$24.3 P/Share
|
|
Feb 12
2019
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Open market or private sale
|
Direct |
73,727
-58.89%
|
$5,750,706
$78.62 P/Share
|
|
Feb 12
2019
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
73,727
+25.38%
|
$2,727,899
$37.93 P/Share
|
|
Feb 08
2019
|
Leslie A Brun Director |
SELL
Open market or private sale
|
Direct |
3,052
-61.04%
|
$235,004
$77.22 P/Share
|
|
Feb 08
2019
|
Leslie A Brun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$120,000
$24.3 P/Share
|
|
Feb 05
2019
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
231,566
-25.07%
|
$18,062,148
$78.08 P/Share
|
|
Feb 05
2019
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
231,566
+20.05%
|
$9,031,074
$39.29 P/Share
|
|
Feb 04
2019
|
Thomas H Glocer Director |
SELL
Open market or private sale
|
Direct |
10,000
-66.23%
|
$750,000
$75.96 P/Share
|
|
Feb 04
2019
|
Thomas H Glocer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.99%
|
$290,000
$29.74 P/Share
|